超越参与:评估患者在瘤学临床试验设计中的作用
Eliya Farah1, Matthew Kenney1, Anris Kica1
1Life-Saving Therapies Network, 173 Heath Street, Ottawa, ON K1H 8L6, Canada.
Current oncology (Toronto, Ont.)
|September 27, 2023
概括
在瘤学临床试验设计中积极参与患者改善了结果和患者体验. 优先考虑患者价值对未来的癌症研究至关重要,超越了简单的参与.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 患者参与 患者参与
背景情况:
- 从历史上看,瘤学临床试验依赖于专家,在设计中患者的投入有限.
- 患者参与是关键,但他们在决策中的积极作用受到限制.
研究的目的:
- 审查有关瘤学临床试验设计的积极患者参与的文献.
- 评估患者参与对临床试验结果的影响.
主要方法:
- 在 MEDLINE (Ovid) 和 EMBASE.中进行了系统的文献搜索.
- 包括专注于患者参与癌症临床研究设计的研究.
主要成果:
- 七项研究符合资格标准,突出了积极参与患者的好处.
- 收益包括增强的招聘策略和更加以患者为中心的结果.
- 患者参与导致有形的发展 (例如,资源) 和间接的影响 (例如,坚持).
结论:
- 未来的瘤学试验必须优先考虑患者的价值观和观点.
- 监管机构应该通过指导方针鼓励以患者为中心.
- 患者参与研究应该超越参与到积极的设计贡献.
相关概念视频
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Nursing Ethical Principles II
1.0K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
145
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
145
Cancer Survival Analysis
380
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
380
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


